Oak Associates LTD Innoviva, Inc. Transaction History

Oak Associates LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$9.33 - $12.48 $221,447 - $296,212	-23,735 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$8.11 - $15.23 $2,635 - $4,949	-325 Reduced 1.35%	23,735 $279,000
Q1 2019 May 09, 2019	SELL	$13.69 - $20.06 $82,345 - $120,660	-6,015 Reduced 20.0%	24,060 $338,000
Q1 2018 May 14, 2018	BUY	$13.8 - $16.99 $415,035 - $510,974	30,075 New	30,075 $501,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Oak Associates LTD , based on Form 13F filings with the SEC.

Stay updated on Oak Associates LTD with notifications on news.